机构：[1]The First Department of Breast Surgery, The Third Affiliated Hospital of Kunming MedicalUniversity, Tumor Hospital of Yunnan Province, Kunming, China[2]The First Department of Medical Oncology, The Third Affiliated Hospital of Kunming MedicalUniversity, Tumor Hospital of Yunnan Province, Kunming, China
OBJECTIVE: MicroRNAs has been proved to play vital roles in many biological processes. In the present study, the expression profile of oncogenic miR-155 in the activated antitumor cytotoxic T lymphocytes generated by the fusion of dendritic cells with breast carcinoma cells has been demonstrated.
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2017]版：
大类|4 区医学
小类|4 区药学
最新[2023]版：
大类|4 区医学
小类|4 区药学
第一作者：
第一作者机构：[1]The First Department of Breast Surgery, The Third Affiliated Hospital of Kunming MedicalUniversity, Tumor Hospital of Yunnan Province, Kunming, China
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang J,Li Y.Oncogenic miR-155 down-regulated upon activation of antitumor cytotoxic T lymphocytes by the fusion of dendritic cells with breast carcinoma cells[J].European review for medical and pharmacological sciences.2017,21(5):1027-1031.
APA：
Zhang, J&Li, Y.(2017).Oncogenic miR-155 down-regulated upon activation of antitumor cytotoxic T lymphocytes by the fusion of dendritic cells with breast carcinoma cells.European review for medical and pharmacological sciences,21,(5)
MLA：
Zhang, J,et al."Oncogenic miR-155 down-regulated upon activation of antitumor cytotoxic T lymphocytes by the fusion of dendritic cells with breast carcinoma cells".European review for medical and pharmacological sciences 21..5(2017):1027-1031
